Author: WTN News

A Wauwatosa-based biotechnology firm developing an instrument for testing new drugs on genetically-engineered heart tissue has been awarded almost $100,000 from the National Institutes of Health. InvivoSciences will use the money to optimize its technology for commercialization in 2007....

A research team led by pediatric hematologist Robert Montgomery has received a five-year, $9.7 million project grant to conduct genetic studies into a hereditary bleeding disorder known as Von Willebrand disease. The grant was issued by the National Heart, Lung, and Blood Institute....

If you're like a lot of technology and life-science executives, you wonder where your next venture round will come from, and who is competing for those same dollars. If you're not familiar with investors, Private Placements columnist Matt Storms suggests you consider intermediaries known as...

TeraMedica Healthcare Technology, a Milwaukee-based medical informatics company, has partnered with the University of California-Davis Cancer Center to install an information manager with oncology-specific electronic medical record technology. As part of the deal, UC-Davis will provide expertise for TeraMedica's Oncology Advisory Board....

Imago Scientific Instruments has sold one of its atom probe microscopes to Iowa State University's College of Engineering for use later this fall. According to the company, the microscope could lead to advances in energy, healthcare, and anti-terrorism efforts....

Johnson Controls, Inc., has struck a preliminary deal to buy the automotive battery business of Fiamm, a global automotive components manufacturer. If approved, the deal will allow Johnson Controls to expand its automotive aftermarket presence in fast-growing Eastern European nations....

The beta test, once used only to test and prepare products for the "prime time" of market competition, is cynically being used as a mechanism to woo investors and lock out competitors, according columnist Chris Shipley. In this edition of DEMO Letter, Shipley calls out...

Madison's bioscience business community is widely known as one of the premier locations for research collaboration and growth, but the arrival of Northwestern University's Caden Biosciences could be a sign that Madison has reached a "critical mass" of talent and technological resources....

Wisconsin may never be Silicon Valley when it comes to entrepreneurial churn, but it has the capacity to become less risk averse. That was one of several messages to come out of the ninth annual E-Business Best Practices and Emerging Technologies Conference....